Comprehensive and accurate cardiovascular disease diagnosis support
The series of cardiac biomarker parameters of Wantai BioPharm are complete and have excellent performance. They include relevant indicators for cardiovascular diseases such as myocardial injury, myocardial infarction, and heart failure, providing comprehensive and accurate diagnostic support for cardiovascular diseases in clinical practice. The highly sensitive detections of Hs-cTnT and Hs-cTnI can identify myocardial injury at an early stage. BNP and NT-proBNP help with the assessment of heart failure conditions and prognosis management. Combined with characteristic indicators such as H-FABP, ST2, and Lp-PLA2, etc., it can meet diverse clinical needs, provide reliable diagnostic evidence for doctors, facilitate precise diagnosis and treatment, and jointly safeguard the life defense line of patients!

Myocardial injury markers
- Hs-cTnT
- Hs-cTnI
- CK-MB
- Myo
- H-FABP
- Hs-CRP
- Lp-PLA2

Heart failure markers
- BNP
- ST2
- NT-proBNP
Product advantages

Complete parameters
The dual detection capability covers Hs-cTnT/Hs-cTnI and BNP/ NT-proBNP to meet different clinical needs

High performance detection
High sensitivity and specificity ensure accurate and reliable detection results

Rapid diagnosis
Early recognition of myocardial injury, shortening the diagnosis time window, and helping timely treatment
Clinical Application
Star products in the series of cardiac biomarkers enable the management of the entire disease course from myocardial injury to heart failure, focus on disease management, and contribute to the effectiveness of diagnosis and treatment.

Myocardial Injury

Angina Pectoris

Myocardial Infarction

Heart Failure
For more information : wtexport@ystwt.com
